Jacobs Levy Equity Management’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Sell
211,272
-13,686
-6% -$106K 0.01% 657
2025
Q4
$1.84M Buy
224,958
+6,535
+3% +$59K 0.01% 594
2025
Q3
$1.94M Sell
218,423
-93,985
-30% -$594K 0.01% 597
2025
Q2
$1.63M Sell
312,408
-118,730
-28% -$604K 0.01% 663
2025
Q1
$2.34M Sell
431,138
-102,058
-19% -$482K 0.01% 626
2024
Q4
$2.44M Buy
533,196
+177,856
+50% +$911K 0.01% 561
2024
Q3
$1.85M Buy
355,340
+265,969
+298% +$1.2M 0.01% 622
2024
Q2
$247K Buy
+89,371
New +$223K ﹤0.01% 903

Other funds holding AVAH

Jacobs Levy Equity Management's AVAH Position: Q1 2026 in Review

Jacobs Levy Equity Management reduced its Aveanna Healthcare (AVAH) stake by 6.1% in Q1 2026, selling an estimated $106K and leaving 211,272 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #657.

Jacobs Levy Equity Management first reported a position in AVAH in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.44M in Q4 2024. 198 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.

  • Jacobs Levy Equity Management held 211,272 shares of Aveanna Healthcare worth $1.36M as of Q1 2026.
  • Jacobs Levy Equity Management sold 13,686 Aveanna Healthcare shares in Q1 2026, an estimated $106K.
  • Aveanna Healthcare made up 0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #657 holding.
  • Jacobs Levy Equity Management first reported a position in Aveanna Healthcare in Q2 2024 and has held it in 8 quarters since.
  • Jacobs Levy Equity Management's Aveanna Healthcare position peaked at $2.44M in Q4 2024.
  • 198 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.